Structure, Synthesis and Inhibition Mechanism of Nucleoside Analogues as HIV-1 Reverse Transcriptase Inhibitors (NRTIs). 2021

Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
Graduate School of Science, Department of Chemistry, Nagoya University Furo-cho, Chikusa-ku, Nagoya, Aichi, 464-8602, Japan.

Acquired immunodeficiency syndrome (AIDS) is caused by infection with the human immunodeficiency virus (HIV). Although treatments against HIV infection are available, AIDS remains a serious disease that causes many deaths annually. Although a variety of anti-HIV drugs have been synthesized and marketed to treat HIV-infected patients, nucleoside analogue reverse transcriptase inhibitors (NRTIs), which mimic nucleosides, are used extensively and remain a subject of interest to medicinal chemists. However, HIV has acquired drug resistance against NRTIs, and thus the struggle to find novel therapies continues. In this review, we trace the trajectory of NRTIs, focusing on the synthesis, mechanisms of action and applications of NRTIs that have been developed.

UI MeSH Term Description Entries
D009705 Nucleosides Purine or pyrimidine bases attached to a ribose or deoxyribose. (From King & Stansfield, A Dictionary of Genetics, 4th ed) Nucleoside,Nucleoside Analog,Nucleoside Analogs,Analog, Nucleoside,Analogs, Nucleoside
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D054303 HIV Reverse Transcriptase A reverse transcriptase encoded by the POL GENE of HIV. It is a heterodimer of 66 kDa and 51 kDa subunits that are derived from a common precursor protein. The heterodimer also includes an RNAse H activity (RIBONUCLEASE H, HUMAN IMMUNODEFICIENCY VIRUS) that plays an essential role the viral replication process. Reverse Transcriptase, HIV,Reverse Transcriptase, Human Immunodeficiency Virus,Transcriptase, HIV Reverse
D018894 Reverse Transcriptase Inhibitors Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template. Reverse Transcriptase Inhibitor,Inhibitors, Reverse Transcriptase,Inhibitor, Reverse Transcriptase,Transcriptase Inhibitor, Reverse
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV

Related Publications

Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
September 2000, Cellular and molecular life sciences : CMLS,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
February 2014, Antiviral research,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
April 1995, Nature structural biology,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
September 2004, The international journal of biochemistry & cell biology,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
October 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
December 2023, Ageing research reviews,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
January 2012, PloS one,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
July 2013, ChemMedChem,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
December 2004, Journal of enzyme inhibition and medicinal chemistry,
Yuki Yoshida, and Masakazu Honma, and Yasuaki Kimura, and Hiroshi Abe
October 2022, European journal of medicinal chemistry,
Copied contents to your clipboard!